Trial Information
Pancreatic Islet Transplantation in Patients With Type 1 Diabetes Mellitus
Inclusion Criteria:
- Patients with type 1 diabetes mellitus, who have a stable functioning renal
transplant, are taking the appropriate maintenance immunosuppression and have no
severe health problems that preclude them receiving an islet transplant will be
considered for inclusion.
Exclusion Criteria:
- Have a history of or findings suggestive of unstable diabetic complications (e.g.
active eye disease)
- Active infections (clinically or by laboratory testing)
- History of current malignancy or suspicion of malignancy until properly investigated
and excluded
- Liver or biliary abnormalities
- Unstable cardiovascular disease
- Findings to suggest immunological sensitization or those women who have the potential
to get pregnant and are not using a sufficient method of contraception
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
The functional capability of the islet allograft to normalize glucose metabolism in the absence of insulin therapy.
Outcome Time Frame:
Outcome measures will be assessed at protocol prescribed intervals. Long term outcomes assessment will be measured at 5 years post transplant or all evidence of islet function has ceased plus six months.
Safety Issue:
No
Principal Investigator
Adrian H Cotterell, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Virginia Commonwealth University Health System
Authority:
United States: Food and Drug Administration
Study ID:
VCU IRB 4196
NCT ID:
NCT00784966
Start Date:
August 2011
Completion Date:
September 2017
Related Keywords:
- Type 1 Diabetes Mellitus
- Islet transplantation
- Type 1 Diabetes Mellitus
- Kidney Transplantation
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
Name | Location |
Virginia Commonwealth University Health System |
Richmond, Virginia 23298 |